Bubs Wins Permanent FDA Authorisation as US Retail Sales Surge
BUB: $0.082 -7.87% · MC: $71M
Bubs Australia secured permanent FDA authorisation for three infant formula products, while US retail scan sales rose 46.5% year on year and 10.6% from the previous quarter as distribution expanded to more than 12,000 stores. Quarterly net revenue fell 9.8% year on year to approximately $23 million, and operating cash outflow increased to $6 million; available liquidity was $13 million at quarter-end.

Comments